946414-94-4 Usage
Clinical Use
Monoclonal antibody:
Treatment of advanced (unresectable or metastatic)
melanoma, non-small cell lung cancer, renal cell
carcinoma, classical Hodgkin lymphoma, squamous
cell cancer of the head and neck and urothelial
carcinoma
Drug interactions
Potentially hazardous interactions with other drugs
Live vaccines: avoid concomitant use
Metabolism
The metabolic pathway of nivolumab has not been
investigated. It is expected to be degraded into small
peptides and amino acids via catabolic pathways in the
same way as endogenous IgG
Check Digit Verification of cas no
The CAS Registry Mumber 946414-94-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,6,4,1 and 4 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 946414-94:
(8*9)+(7*4)+(6*6)+(5*4)+(4*1)+(3*4)+(2*9)+(1*4)=194
194 % 10 = 4
So 946414-94-4 is a valid CAS Registry Number.